Stock page
Oncologix Tech Inc (OCLG)
Oncologix Tech Inc is a biopharmaceutical company focused on clinical genetic testing and gene editing technologies. Its offerings include diagnostic solutions for rare genetic diseases through platforms like DNAGO and GenomeGO. The company is engaged in the research and development of gene-based tests and therapies, with current efforts centered on improving diagnostic tools and exploring treatments in the area of genetic disorders.
Quote snapshot
$0.0001
Daily change: —
ExchangeOTCPK
Updated2026-05-09T03:57:09.152528Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|